Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results
Abstract PSICHE (NCT05022914) is a prospective trial to test a [68Ga]Ga- PSMA-11 PET/CT imaging tailored strategy. All evaluable patients had biochemical relapse after surgery and underwent centralized [68Ga]Ga-PSMA-11 PET/CT imaging. The treatment was performed according pre-defined criteria. Observation and re-staging at further PSA progression were proposed to patients with negative PSMA and previous postoperative RT. Prostate bed SRT was proposed to all patients with a negative staging or positive imaging within prostate bed. Stereotactic body radiotherapy (SBRT) to all sites of disease was used for all patients with pelvic nodal recurrence (nodal disease < 2 cm under aortic bifurcation) or oligometastatic disease. At 3 months after treatment, 54.7% of patients had a complete biochemical response Only 2 patients experienced G2 Genitourinary toxicity. No G2 Gastrointestinal toxicity was recorded. A PSMA targeted treatment strategy led to encouraging results and was well tolerated..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
|---|---|
| Enthalten in: |
Clinical & experimental metastasis - 40(2023), 2 vom: Apr., Seite 197-201 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Francolini, Giulio [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: | |
|---|---|
| Themen: |
| Anmerkungen: |
© The Author(s) 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
|---|
| doi: |
10.1007/s10585-023-10204-y |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2134526416 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2134526416 | ||
| 003 | DE-627 | ||
| 005 | 20230510162307.0 | ||
| 007 | tu | ||
| 008 | 230510s2023 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10585-023-10204-y |2 doi | |
| 035 | |a (DE-627)OLC2134526416 | ||
| 035 | |a (DE-He213)s10585-023-10204-y-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.00 |2 bkl | ||
| 100 | 1 | |a Francolini, Giulio |e verfasserin |0 (orcid)0000-0002-1784-7203 |4 aut | |
| 245 | 1 | 0 | |a Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © The Author(s) 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. | ||
| 520 | |a Abstract PSICHE (NCT05022914) is a prospective trial to test a [68Ga]Ga- PSMA-11 PET/CT imaging tailored strategy. All evaluable patients had biochemical relapse after surgery and underwent centralized [68Ga]Ga-PSMA-11 PET/CT imaging. The treatment was performed according pre-defined criteria. Observation and re-staging at further PSA progression were proposed to patients with negative PSMA and previous postoperative RT. Prostate bed SRT was proposed to all patients with a negative staging or positive imaging within prostate bed. Stereotactic body radiotherapy (SBRT) to all sites of disease was used for all patients with pelvic nodal recurrence (nodal disease < 2 cm under aortic bifurcation) or oligometastatic disease. At 3 months after treatment, 54.7% of patients had a complete biochemical response Only 2 patients experienced G2 Genitourinary toxicity. No G2 Gastrointestinal toxicity was recorded. A PSMA targeted treatment strategy led to encouraging results and was well tolerated. | ||
| 650 | 4 | |a Prostate | |
| 650 | 4 | |a Radiotherapy | |
| 650 | 4 | |a Bladder | |
| 650 | 4 | |a Kidney | |
| 700 | 1 | |a Ganovelli, Michele |4 aut | |
| 700 | 1 | |a Di Cataldo, Vanessa |4 aut | |
| 700 | 1 | |a Detti, Beatrice |0 (orcid)0000-0001-5799-5924 |4 aut | |
| 700 | 1 | |a Caini, Saverio |4 aut | |
| 700 | 1 | |a Loi, Mauro |4 aut | |
| 700 | 1 | |a Simontacchi, Gabriele |4 aut | |
| 700 | 1 | |a Desideri, Isacco |4 aut | |
| 700 | 1 | |a Greto, Daniela |4 aut | |
| 700 | 1 | |a Valzano, Marianna |4 aut | |
| 700 | 1 | |a Serni, Sergio |4 aut | |
| 700 | 1 | |a Vaggelli, Luca |4 aut | |
| 700 | 1 | |a Salvestrini, Viola |4 aut | |
| 700 | 1 | |a Visani, Luca |4 aut | |
| 700 | 1 | |a Becherini, Carlotta |4 aut | |
| 700 | 1 | |a Olmetto, Emanuela |4 aut | |
| 700 | 1 | |a Franzese, Ciro |4 aut | |
| 700 | 1 | |a Baldaccini, Davide |4 aut | |
| 700 | 1 | |a Scorsetti, Marta |4 aut | |
| 700 | 1 | |a Sollini, Martina |4 aut | |
| 700 | 1 | |a Chiti, Arturo |4 aut | |
| 700 | 1 | |a Meattini, Icro |4 aut | |
| 700 | 1 | |a Valicenti, Richard K. |4 aut | |
| 700 | 1 | |a Livi, Lorenzo |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical & experimental metastasis |d Springer Netherlands, 1983 |g 40(2023), 2 vom: Apr., Seite 197-201 |w (DE-627)167916343 |w (DE-600)604952-7 |w (DE-576)015903176 |x 0262-0898 |7 nnns |
| 773 | 1 | 8 | |g volume:40 |g year:2023 |g number:2 |g month:04 |g pages:197-201 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s10585-023-10204-y |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 936 | b | k | |a 44.00 |q VZ |
| 951 | |a AR | ||
| 952 | |d 40 |j 2023 |e 2 |c 04 |h 197-201 | ||